Going on Trial: Trofinetide approval for Rett; n-of-1 ASO therapies; cord-blood deals

This month’s issue of the Going on Trial newsletter examines personalized therapies for rare conditions, Acadia’s new drug for Rett syndrome and developments in a cord-blood program, among other autism-related drug trial news.

Episode metadata supplied by the publisher feed · Published Apr 12, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Going on Trial: Trofinetide approval for Rett; n-of-1 ASO therapies; cord-blood deals

0:00 8:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Audio research news?

This episode is 8 minutes long.

When was this Audio research news episode published?

This episode was published on April 12, 2023.

Can I download this Audio research news episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!